Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIb study of redasemtide versus placebo in adults with acute ischemic stroke
CTR20233707Phase 2Active
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Apr 2024
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of redasemtide in ischemic stroke, sponsored by Shionogi & Co., Ltd.. Started Apr 2024; status: active.
02
Drugs
redasemtide
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on CTR20233707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20233707.